Evidence map›Paper›PMID 40738736›Full record

ArticleRNA (New York, N.Y.)2025

Stress granules promote quiescence by enhancing p21 levels and reducing phospho-Rb.

Anthony Khong, Nina Ripin, Luisa Macedo de Vasconcelos, Victor Passanisi, Sabrina Spencer, Roy Parker

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anthony KhongDepartment of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, USA roy.parker@colorado.edu khonga@nus.edu.sg.
Nina RipinDepartment of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, USA.
Luisa Macedo de VasconcelosDepartment of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, USA.
Victor PassanisiDepartment of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, USA.
Sabrina SpencerDepartment of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, USA.
Roy ParkerDepartment of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, USA roy.parker@colorado.edu khonga@nus.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the integrated stress response (ISR), most mRNAs exit translation and some condense into stress granules. Stress granules that form during chemotherapy can promote cancer cell survival and chemoresistance by an unknown mechanism. Cells can also spontaneously trigger the ISR at low levels, which promotes cellular quiescence where cells exit the cell cycle and are resistant to therapeutic agents. We hypothesized that the ability of cells to form stress granules might be a critical signal to drive cells into quiescence. Herein, we provide several observations that suggest stress granules enhance cell survival and chemoresistance by promoting cellular quiescence. The mechanism by which stress granules promote quiescence is by stimulating p21 expression, leading to inhibition of Rb phosphorylation. These results demonstrate that stress granule formation is sufficient to trigger cellular quiescence and argue that inhibitors of stress granules may be effective in combination with chemotherapy to limit the development of chemoresistance in treating human tumors.

Indexed as

Cyclin-Dependent Kinase Inhibitor p21Retinoblastoma ProteinStress GranulesCell CycleCell Line, TumorCell SurvivalDrug Resistance, NeoplasmHumansPhosphorylationStress, PhysiologicalCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Retinoblastoma Proteincell cycleG3BPp21quiescencestress granulesvinorelbine

Identifiers

PMID40738736
PMCPMC12439591

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.